TREAT: Darbepoetin alfa fails in anemic diabetics with CKD
Links shared publicly online about this topic.
- 1,638total visits
TREAT: Darbepoetin alfa fails in anemic diabetics with CKD
No differences were seen between groups, except in strokes, which were twice as high in the active-treatment group. Anticipated improvements in fatigue scores were modest and not clinically meaningful, investigators say.
View full resource at theheart.org
Tags: Anemia, Anemia Medication, Diabetes, Kidney Health, Urinary System, Aranesp, Event
Most Recently Shared on October 31, 2009 at 1:04 am By:
heartwire: No TREAT: Darbepoetin alfa fails to reduce CV or renal events in anemic diabetics with CKD http://bit.ly/2vsyPY
TREAT: Darbepoetin alfa fails in anemic diabetics with CKD | theheart.org
theheart.org — “Articles written by renowned physicians on recent developments and advancements in brain, kidney and peripheral medicine. Sign up for regular industry updates.” View full resource at theheart.org
Most Recently Shared on October 18, 2010 at 3:24 pm By:
For full coverage of the TREAT trial, presented in October 2009 by Dr Marc Pfeffer, see heartwire's coverage at http://bit.ly/4oSz6k.
Advertisement
